Coltac Therapeutics

Preclinical Pharmaceutical Developing Bacteria-based Synthetic Positive Selection Screening System

Health Tech & Life Sciences

Active

Seed Ra'anana Founded 2022

Total raised

$5.0M

Last: Seed 2022-04

Stage

Seed

Founded

2022

Headcount

Ra'anana

Sector

Health Tech & Life Sciences

About

Coltac Therapeutics develops and research solutions of discovering the next generation of molecular glues by harnessing the power of our bacteria-based, synthetic positive selection screening system.

Funding history · 1 round · $5.0M total

2022-04

Seed Undisclosed

Sectors & technology

Primary sector

Health Tech & Life Sciences

Sub-sectors

Health Tech & Life SciencesPharma & Medical BiotechnologyBiomaterials & Tissue EngineeringDrugs Discovery & Development

Target customers

Healthcare & Life SciencesLife SciencesBiotechnologyPharmaceuticalsHealthcare

Business model

B2B

Name	Coltac Therapeutics
Slug	coltac-therapeutics
Type	Israeli Startup
Founded	2022
HQ city	Ra'anana
HQ country	IL
Primary sector	[object Object]
Sectors	[object Object], [object Object], [object Object], [object Object]
Business models	B2B
Target customers	[object Object], [object Object], [object Object], [object Object], [object Object]
Status	active
Current stage	Seed
Public stage	Seed
Total raised (USD)	5,000,000
Last round	Seed (2022-04)
Crunchbase ID	coltac-therapeutics
Israeli Companies Registrar	516542305

Name	Role	LinkedIn
Gali Prag
Hana Boocholez

Coltac Therapeutics

About

Funding history · 1 round · $5.0M total

Sectors & technology

Tags